Research programme: D-amino acid oxidase inhibitors - Sepracor
Alternative Names: DAAO inhibitors - SepracorLatest Information Update: 28 Oct 2010
At a glance
- Originator Sepracor
- Class
- Mechanism of Action D amino acid oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders; Pain; Psychotic disorders; Schizophrenia
Most Recent Events
- 13 Oct 2010 Discontinued - Preclinical for Cognition disorders in USA (unspecified route)
- 13 Oct 2010 Discontinued - Preclinical for Pain in USA (unspecified route)
- 13 Oct 2010 Discontinued - Preclinical for Psychotic disorders in USA (unspecified route)